We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
- Authors
Fleming, Gini F; Brunetto, Virginia L; Cella, David; Look, Katherine Y; Reid, Gary C; Munkarah, Adnan R; Kline, Richard; Burger, Robert A; Goodman, Annekathryn; Burks, R Tucker
- Abstract
To determine whether the addition of paclitaxel to doxorubicin plus cisplatin improves overall survival (OS) in women with advanced or recurrent endometrial carcinoma. Secondary comparisons included progression-free survival (PFS), response rate (RR), and toxicities.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Vol 22, Issue 11, p2159
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2004.07.184